Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.

MLA

Hoffman, Karen E., et al. “Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 36, no. 29, Oct. 2018, pp. 2943–49. EBSCOhost, https://doi.org/10.1200/JCO.2018.77.9868.

APA

Hoffman, K. E., Voong, K. R., Levy, L. B., Allen, P. K., Choi, S., Schlembach, P. J., Lee, A. K., McGuire, S. E., Nguyen, Q., Pugh, T. J., Frank, S. J., Kudchadker, R. J., Du, W., & Kuban, D. A. (2018). Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(29), 2943–2949. https://doi.org/10.1200/JCO.2018.77.9868

Chicago

Hoffman, Karen E, K Ranh Voong, Lawrence B Levy, Pamela K Allen, Seungtaek Choi, Pamela J Schlembach, Andrew K Lee, et al. 2018. “Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 36 (29): 2943–49. doi:10.1200/JCO.2018.77.9868.